|
May 2
|
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
|
|
May 2
|
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
|
|
May 2
|
Moderna Maintains Full-Year Sales Guidance Following First-Quarter Beat
|
|
May 2
|
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
|
|
May 2
|
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Moderna ends gene editing alliance with Metagenomi
|
|
May 2
|
Moderna posts quarterly sales beat, smaller loss than expected
|
|
May 2
|
Moderna quarterly sales beat expectations but plummet from previous year
|
|
May 2
|
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
|
|
May 1
|
Apple, Novo Nordisk earnings, jobless claims: What to watch
|
|
May 1
|
Why Earnings Season Could Be Great for Moderna (MRNA)
|
|
Apr 30
|
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
|
|
Apr 30
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Apr 30
|
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO Compensation Package
|
|
Apr 29
|
mRNA Is Promising A Breakthrough In Fighting Cancer
|
|
Apr 29
|
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
|
|
Apr 29
|
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
|
|
Apr 26
|
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
|
|
Apr 26
|
Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 26
|
Should You Buy Moderna Before May 12?
|